ArticleFrontiers in medicine2025
Rapid progression and extensive lymph node metastases of papillary thyroid carcinoma in an HIV-positive patient: a Case Report.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human Immunodeficiency Virus (HIV)-induced immunosuppression represents a potential risk factor for tumorigenesis and cancer progression, though existing studies have not conclusively established the association between HIV infection and the proliferation/metastasis of papillary thyroid carcinoma (PTC). We present a rare case of a 26-year-old male patient who exhibited rapid cervical tumor enlargement with extensive high-burden lymphatic metastasis following HIV infection. Imaging examinations revealed a cystic-solid thyroid mass with multiple lymphadenopathies in bilateral cervical regions, mediastinum, and axillae. The patient initiated antiretroviral therapy (ART) upon HIV diagnosis and subsequently underwent surgical intervention followed by adjuvant iodine-131 therapy and Thyroid hormone suppression therapy. No recurrence was observed during the 15-month follow-up period. This report highlights a potential association between HIV infection and aggressive progression/metastatic potential in thyroid carcinoma, while highlighting the critical importance of personalized treatment strategies for optimizing clinical outcomes in HIV patients with concurrent PTC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.